CHIP: Cardiovascular Health Improvement Project

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT02306200
Collaborator
(none)
9,999
1
444
22.5

Study Details

Study Description

Brief Summary

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Detailed Description

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls. The aims of the study are to collect biological specimens (blood, plasma, serum, aortic tissue) and family history; establish a biobank, establish a comprehensive database with information from consented patients, and provide researchers with high quality well annotated DNA samples with demographic and clinical information.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
9999 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Cardiovascular Health Improvement Project
Study Start Date :
Aug 1, 2013
Anticipated Primary Completion Date :
Aug 1, 2050
Anticipated Study Completion Date :
Aug 1, 2050

Arms and Interventions

Arm Intervention/Treatment
Aortic Disease

Patients with a diagnosis of any form of Aortic Disease

Controls

Patients without a diagnosis of Aortic Disease

Outcome Measures

Primary Outcome Measures

  1. Establishing a biobank of patients with Aortic Disease [40 years]

    Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Any patient over the age of 18 who is able/willing to give informed consent

  • Patients <18 years of age with parental consent and assent (if assent is applicable for their age)

  • Diagnosis of:

  • aortic pathology potentially due to a known or suspected inherited condition

  • Idiopathic aortic aneurysm

  • Interesting of novel vascular pathology in the aorta or main branches

  • Family history of aortic or vascular disease

  • Other cardiovascular disease

  • Healthy controls with no apparent cardiovascular disease

Exclusion Criteria:
  • Not willing or able to sign the consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Marion A Hofmann Bowman, PhD, MD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marion Hofmann Bowman, Associate Professor of Internal Medicine, University of Michigan
ClinicalTrials.gov Identifier:
NCT02306200
Other Study ID Numbers:
  • HUM00052866
First Posted:
Dec 3, 2014
Last Update Posted:
Jun 29, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marion Hofmann Bowman, Associate Professor of Internal Medicine, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 29, 2022